請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/78169
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 王勝仕 | |
dc.contributor.author | Hsin-Yi Duan | en |
dc.contributor.author | 段欣怡 | zh_TW |
dc.date.accessioned | 2021-07-11T14:44:32Z | - |
dc.date.available | 2021-10-14 | |
dc.date.copyright | 2016-10-14 | |
dc.date.issued | 2016 | |
dc.date.submitted | 2016-08-02 | |
dc.identifier.citation | 1. Root, T., OphthoBook 1ed. 2009.
2. Jay H. Krachmer, M.J.M., Edward J. Holland, Cornea, Fundamentals, Diagnosis and Management. 2005. : p. 3-26. 3. Beuerman, R.W. and L. Pedroza, Ultrastructure of the human cornea. Microsc Res Tech, 1996. 33(4): p. 320-335. 4. Rozsa, A.J. and R.W. Beuerman, Density and organization of free nerve endings in the corneal epithelium of the rabbit. Pain, 1982. 14(2): p. 105-120. 5. Pfister, R.R., The normal surface of corneal epithelium: a scanning electron microscopic study. Invest Ophthalmol, 1973. 12(9): p. 654-668. 6. Chirila, T.V., et al., Artificial cornea. Progress in Polymer Science, 1998. 23(3): p. 447-473. 7. Asbell P, B.D., Cornea overview. 2010. 1: p. 552-531. 8. George M. Bohigian, E.H.E.J., et al., Report of the organ transplant panel. Corneal transplantation. Council on Scientific Affairs. JAMA, 1988. 259(5): p. 719-722. 9. W J Armitage, A.B.T., D F P Larkin, The first successful full-thickness corneal transplant: a commentary on Eduard Zirm's lanmark paper of 1906. Br J Ophthalmol, 2006: p. 1222–1223. 10. Klebe, S., D.J. Coster, and K.A. Williams, Pathological aspects of the failed corneal graft. Diagnostic Histopathology, 2015. 21(1): p. 11-18. 11. Hjortdal, J., Corneal Transplantation. 2016: Springer. 12. Claes H Dohlman, M.H.-D., Bilal F Khan, Kimberly Sippel, and J.V.A.a.J.M. Graney, Introduction to the use of the Boston keratoprosthesis. Expert Rev. Ophthalmol., 2006: p. 41-48. 13. Foulks, G.N. and F. Sanfilippo, Beneficial-Effects of Histocompatibility in High-Risk Corneal Transplantation. American Journal of Ophthalmology, 1982. 94(5): p. 622-629. 14. Group, T.C.C.T.S.R., The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. . Arch Ophthalmol, 1992. 110(10): p. 1392-1403. 15. Kadakia, A., et al., Hybrid superporous scaffolds: an application for cornea tissue engineering. Crit Rev Biomed Eng, 2008. 36(5-6): p. 441-471. 16. David Myung, et al., Interprenetrating polymer network hydrogel corneal prosthesis. 2011: United State. 17. Isager, P., J.O. Hjortdal, and N. Ehlers, Stability of graft refractive power after penetrating keratoplasty. Acta Ophthalmol Scand, 2000. 78(6): p. 623-626. 18. Kamp, M.T., et al., Patient-reported symptoms associated with graft reactions in high-risk patients in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Cornea, 1995. 14(1): p. 43-48. 19. Tan, D.T., A. Anshu, and J.S. Mehta, Paradigm shifts in corneal transplantation. Ann Acad Med Singapore, 2009. 38(4): p. 332-338. 20. Amayem, A.F., I.M. Hamdi, and M.M. Hamdi, Refractive and visual outcomes of penetrating keratoplasty versus deep anterior lamellar keratoplasty with hydrodissection for treatment of keratoconus. Cornea, 2013. 32(4): p. 2-5. 21. Shimazaki, J., et al., Randomized clinical trial of deep lamellar keratoplasty vs penetrating keratoplasty. Am J Ophthalmol, 2002. 134(2): p. 159-165. 22. Anshu, A., et al., Endothelial keratoplasty: a revolution in evolution. Surv Ophthalmol, 2012. 57(3): p. 236-252. 23. Anshu, A., M.O. Price, and F.W. Price, Risk of Corneal Transplant Rejection Significantly Reduced with Descemet's Membrane Endothelial Keratoplasty. Ophthalmology, 2012. 119(3): p. 536-540. 24. Melles, G.R., et al., Descemet membrane endothelial keratoplasty (DMEK). Cornea, 2006. 25(8): p. 987-990. 25. Mader, T.H. and R.D. Stulting, Keratoconjunctivitis sicca caused by diphenoxylate hydrochloride with atropine sulfate (Lomotil). Am J Ophthalmol, 1991. 111(3): p. 377-378. 26. Barnham, J.J. and M.J. Roper-Hall, Keratoprosthesis: a long-term review. Br J Ophthalmol, 1983. 67(7): p. 468-474. 27. Carlsson, D.J., et al., Bioengineered corneas: how close are we? Curr Opin Ophthalmol, 2003. 14(4): p. 192-197. 28. Aldave, A.J., et al., Epithelial debridement and Bowman's layer polishing for visually significant epithelial irregularity and recurrent corneal erosions. Cornea, 2009. 28(10): p. 1085-1090. 29. Institute, W.E. Artificial Cornea. Available from: http://www.hopkinsmedicine.org/wilmer/conditions/artificial_cornea.html. 30. Chirila, T.V., An overview of the development of artificial corneas with porous skirts and the use of PHEMA for such an application. Biomaterials, 2001. 22(24): p. 3311-3317. 31. Myron Yanoff, J.S.D., Ophthalmology. 4 ed. 2014: Elsevier. 32. Magalhaes, F.P., L.B. Sousa, and L.A. Oliveira, Boston type I keratoprosthesis: Review. Arq Bras Oftalmol, 2012. 75(3): p. 218-222. 33. Avadhanam, V.S., H.E. Smith, and C. Liu, Keratoprostheses for corneal blindness: a review of contemporary devices. Clin Ophthalmol, 2015. 9: p. 697-720. 34. M. Soledad Cortina , J.d.l.C., Keratoprostheses and Artificial Corneas. 2015: Springer. 35. Richard S. Koplin, E.I.W. and J.A.S. David C. Ritterband, Corneal Transplantation: Keratoprosthesis, in The Scrub's Bible. 2013, Springer. p. 113-117. 36. Klufas, M.A. and K.A. Colby, The Boston keratoprosthesis. Int Ophthalmol Clin, 2010. 50(3): p. 161-175. 37. Thoft, R.A., J. Friend, and C.H. Dohlman, Corneal glucose flux. II. Its response to anterior chamber blockade and endothelial damage. Arch Ophthalmol, 1971. 86(6): p. 685-691. 38. Riley, M.V., Glucose and oxygen utilization by the rabbit cornea. Exp Eye Res, 1969. 8(2): p. 193-200. 39. Turss, R., J. Friend, and C.H. Dohlman, Effect of a corneal fluid barrier on the nutrition of the epithelium. Exp Eye Res, 1970. 9(2): p. 254-259. 40. Adler, F.H., Robert A. Moses, and William M. Hart., Adler's physiology of the eye: Clinical application. 8th ed. 1987. 41. Brown, S.I. and C.H. Dohlman, A Buried Corneal Implant Serving as a Barrier to Fluid. Archives of Ophthalmology, 1965. 73(5): p. 635-638 42. Harissi-Dagher, M., et al., Importance of nutrition to corneal grafts when used as a carrier of the Boston Keratoprosthesis. Cornea, 2007. 26(5): p. 564-568. 43. Joyce Y. Wong, J.D.B., Biomaterials. 2007: CRC Press 44. Niinomi, M., Metallic biomaterials. J Artif Organs, 2008. 11(3): p. 105-110. 45. Ament, J.D., et al., The Boston Keratoprosthesis: comparing corneal epithelial cell compatibility with titanium and PMMA. Cornea, 2009. 28(7): p. 808-811. 46. Chak, G. and J.V. Aquavella, A safe Nd:YAG retroprosthetic membrane removal technique for keratoprosthesis. Cornea, 2010. 29(10): p. 1169-1172. 47. Claes H Dohlman*a, M.H.-D., Bilal F Khanb, Kimberly Sippelb, James V Aquavellac & John M Graneyd, Introduction to the use of the Boston keratoprosthesis. 2014. 1(1): p. 41-48. 48. Todani, A., et al., Titanium back plate for a PMMA keratoprosthesis: clinical outcomes. Graefes Arch Clin Exp Ophthalmol, 2011. 249(10): p. 1515-1518. 49. Boston Kpro news. 2013; Available from: https://www.masseyeandear.org/~/media/testupload/files/kpro-news-vol9-aug-2013.pdf?la=en. 50. Ament, J.D., et al., Role for Ipsilateral Autologous Corneas as a Carrier for the Boston Keratoprosthesis: The Africa Experience. Archives of Ophthalmology, 2010. 128(6): p. 795-797. 51. Edward J Holland, M.J.M.a.W.B.L., Ocular Surface Disease: Cornea, Conjunctiva and Tear Film 2013: Elsevier. 52. Aquavella, J.V., et al., Keratoprosthesis: current techniques. Cornea, 2006. 25(6): p. 656-662. 53. Zerbe, B.L., et al., Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology, 2006. 113(10): p. 1779 -1787. 54. Aldave, A.J., et al., The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology, 2009. 116(4): p. 640-651. 55. Bradley, J.C., et al., Boston type 1 keratoprosthesis: the university of california davis experience. Cornea, 2009. 28(3): p. 321-327. 56. Dunlap, K., et al., Short-term visual outcomes of Boston type 1 keratoprosthesis implantation. Ophthalmology, 2010. 117(4): p. 687-692. 57. Robert, M.C. and M. Harissi-Dagher, Boston type 1 keratoprosthesis: the CHUM experience. Can J Ophthalmol, 2011. 46(2): p. 164-168. 58. Aldave, A.J., et al., International results with the Boston type I keratoprosthesis. Ophthalmology, 2012. 119(8): p. 1530-1538. 59. Ciolino, J.B., et al., Retention of the Boston keratoprosthesis type 1: multicenter study results. Ophthalmology, 2013. 120(6): p. 1195-1200. 60. Lee, W.B., et al., Boston Keratoprosthesis: Outcomes and Complications: A Report by the American Academy of Ophthalmology. Ophthalmology, 2015. 122(7): p. 1504-1511. 61. Rudnisky, C.J., et al., Visual Acuity Outcomes of the Boston Keratoprosthesis Type 1: Multicenter Study Results. Am J Ophthalmol, 2016. 162: p. 89-98. 62. Duignan, E.S., et al., Long-term visual acuity, retention and complications observed with the type-I and type-II Boston keratoprostheses in an Irish population. Br J Ophthalmol, 2015. 63. Greiner, M.A., J.Y. Li, and M.J. Mannis, Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology, 2011. 118(8): p. 1543-1550. 64. Kosker, M., et al., Long-Term Results of the Boston Keratoprosthesis for Unilateral Corneal Disease. Cornea, 2015. 34(9): p. 1057-1062. 65. Srikumaran, D., et al., Long-term outcomes of boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort. Ophthalmology, 2014. 121(11): p. 2159-2164. 66. Claes H Dohlman, M.H.-D., Bilal F Khan, Kimberly Sippel, James V Aquavellac & John M Graney, Introduction to the use of the Boston keratoprosthesis. Expert Review of Ophthalmology, 2006. 1(1): p. 41-48. 67. Hicks, C.R., et al., Corneal replacement using a synthetic hydrogel cornea, AlphaCor (TM) device, preliminary outcomes and complications. Eye, 2003. 17(3): p. 385-392. 68. Coassin, M., et al., Histopathologic and immunologic aspects of alphacor artificial corneal failure. Am J Ophthalmol, 2007. 144(5): p. 699-704. 69. Hicks, C.R., et al., Histology of AlphaCor skirts: evaluation of biointegration. Cornea, 2005. 24(8): p. 933-940. 70. Hicks, C.R., et al., AlphaCor: Clinical outcomes. Cornea, 2006. 25(9): p. 1034-42. 71. Jiraskova, N., et al., AlphaCor artificial cornea: clinical outcome. Eye (Lond), 2011. 25(9): p. 1138-1146. 72. Iyer, G., et al., Modified osteo-odonto keratoprosthesis--the Indian experience--results of the first 50 cases. Cornea, 2010. 29(7): p. 771-776. 73. Prof.Dr. Meenu Jain, P.D.V.V., Dr. Rafi Tagoo, MODIFIED OSTEO-ODONTO-KERATOPROSTHESIS. Journal of Dental Sciences & Oral Rehabilitation 2011: p. 18-19. 74. Kim, M.K., et al., Comparative experiments for in vivo fibroplasia and biological stability of four porous polymers intended for use in the Seoul-type keratoprosthesis. Br J Ophthalmol, 2002. 86(7): p. 809-814. 75. Lee, J.H., et al., Development of a newly designed double-fixed Seoul-type keratoprosthesis. Arch Ophthalmol, 2000. 118(12): p. 1673-1678. 76. Kim, M.K., et al., Seoul-type keratoprosthesis: preliminary results of the first 7 human cases. Arch Ophthalmol, 2002. 120(6): p. 761-766. 77. Kim, M.K., et al., Long-term outcome in ocular intractable surface disease with Seoul-type keratoprosthesis. Cornea, 2007. 26(5): p. 546-551. 78. Pineda II R, S.Y., The KeraKlear artificial cornea: a novel keratoprosthesis. Tech Opthalmology., 2009. 7(3): p. 101-104. 79. John T, S.Y., Vargas JM., Foldable artificial cornea offers alternative to corneal transplantation., in Ocular Surg News. 2012. 80. Wang, L., et al., Long-term outcomes and complications of Moscow Eye Microsurgery Complex in Russia (MICOF) keratoprosthesis following ocular surface burns: clinical experience in China. Br J Ophthalmol, 2015. 99(12): p. 1669-1674. 81. Ghaffariyeh, A., et al., Fyodorov-Zuev keratoprosthesis implantation: long-term results in patients with multiple failed corneal grafts. Graefes Archive for Clinical and Experimental Ophthalmology, 2011. 249(1): p. 93-101. 82. Khan, B., E.J. Dudenhoefer, and C.H. Dohlman, Keratoprosthesis: an update. Curr Opin Ophthalmol, 2001. 12(4): p. 282-287. 83. Vijayasekaran, S., et al., Calcification of poly(2-hydroxyethyl methacrylate) hydrogel sponges implanted in the rabbit cornea: a 3-month study. J Biomater Sci Polym Ed, 2000. 11(6): p. 599-615. 84. Tu, Y., et al., Synthetic elastin hydrogels that are coblended with heparin display substantial swelling, increased porosity, and improved cell penetration. J Biomed Mater Res A, 2010. 95(4): p. 1215-1222. 85. Liu, Y., et al., A simple, cross-linked collagen tissue substitute for corneal implantation. Invest Ophthalmol Vis Sci, 2006. 47(5): p. 1869-1875. 86. Kopecek, J., Polymer chemistry: swell gels. Nature, 2002. 417(6887): p. 388-391. 87. Netti, P.A., et al., Hydrogels as an Interface between Bone and an Implant. Biomaterials, 1993. 14(14): p. 1098-1104. 88. Nykanen, V.P.S., et al., Dual-responsive and super absorbing thermally cross-linked hydrogel based on methacrylate substituted polyphosphazene. Soft Matter, 2011. 7(9): p. 4414-4424. 89. Zhang, Y.S., et al., Design and performance of a sericin-alginate interpenetrating network hydrogel for cell and drug delivery. Scientific Reports, 2015. 5: p.1-13 90. Shi, J., M.M. Xing, and W. Zhong, Development of hydrogels and biomimetic regulators as tissue engineering scaffolds. Membranes (Basel), 2012. 2(1): p. 70-90. 91. Kopecek, J., Hydrogel biomaterials: a smart future? Biomaterials, 2007. 28(34): p. 5185-5192. 92. Lin, C.C. and K.S. Anseth, PEG hydrogels for the controlled release of biomolecules in regenerative medicine. Pharm Res, 2009. 26(3): p. 631-643. 93. Escobar-Chavez, J.J., et al., Applications of thermoreversible pluronic F-127 gels in pharmaceutical formulations. Journal of Pharmacy and Pharmaceutical Sciences, 2006. 9(3): p. 339-358. 94. Mata, A., et al., Analysis of connective tissue progenitor cell behavior on polydimethylsiloxane smooth and channel micro-textures. Biomedical Microdevices, 2002. 4(4): p. 267-275. 95. Karkhaneh, A., et al., Novel materials to enhance corneal epithelial cell migration on keratoprosthesis. British Journal of Ophthalmology, 2011. 95(3): p. 405-409. 96. Askadskii, A.A., Computational Materials Science of Polymers. 2003 Cambridge International Science: Cambridge International Science Publishi 97. Goda, T. and K. Ishihara, Soft contact lens biomaterials from bioinspired phospholipid polymers. Expert Review of Medical Devices, 2006. 3(2): p. 167-174. 98. Edward Kimble, B.A., Rudolph Cameron SYMMETRIC SILICONE MACROMERS Polymer Preprint, 2009. 50(2): p. 859-860. 99. Goda, T., et al., Photografting of 2-methacryloyloxyethyl phosphorylcholine from polydimethylsiloxane: Tunable protein repellency and lubrication property. Colloids and Surfaces B-Biointerfaces, 2008. 63(1): p. 64-72. 100. Wong, I. and C.M. Ho, Surface molecular property modifications for poly(dimethylsiloxane) (PDMS) based microfluidic devices. Microfluidics and Nanofluidics, 2009. 7(3): p. 291-306. 101. Schneider, F., et al., Process and material properties of polydimethylsiloxane (PDMS) for Optical MEMS. Sensors and Actuators a-Physical, 2009. 151(2): p. 95-99. 102. Klein, D., Organic chemistry. 1 ed. 2012, Hoboken, N.J.: John Wiley. xxiii, p.1295-1333. 103. Escobar-Chavez, J.J., et al., Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci, 2006. 9(3): p. 339-358. 104. Annabi, N., et al., Controlling the porosity and microarchitecture of hydrogels for tissue engineering. Tissue Eng Part B Rev, 2010. 16(4): p. 371-383. 105. Okay, O., Macroporous copolymer networks. Progress in Polymer Science, 2000. 25(6): p. 711-779. 106. Hao, D.X., et al., The relationship between heterogeneous structures and phase separation in synthesis of uniform PolyDVB microspheres. Polymer, 2009. 50(14): p. 3188-3195. 107. Douglas A. Skoog, F.J.H., Stanley R. Crouch, Principles of Instrumental Analysis 2007. 108. Macosko, C.W., Rheology principles, measurements, and applications. 1994, United states of America: VCH Publishers, Inc. 109. Hou, Y.P., et al., Photo-Cross-Linked PDMSstar-PEG Hydrogels: Synthesis, Characterization, and Potential Application for Tissue Engineering Scaffolds. Biomacromolecules, 2010. 11(3): p. 648-656. 110. Bailey, B.M., et al., Tuning PEG-DA hydrogel properties via solvent-induced phase separation (SIPS). Journal of Materials Chemistry, 2011. 21(46): p. 18776-18782. 111. Tan, F., et al., Fabrication of positively charged poly(ethylene glycol)-diacrylate hydrogel as a bone tissue engineering scaffold. Biomedical Materials, 2012. 7(5): p. 1-10 112. Imani, M., et al., Monitoring of polyethylene glyco ldiacrylate-based hydrogel formation by real time NMR spectroscopy. Iranian Polymer Journal, 2007. 16(1): p. 13-20. 113. Zhong, C., et al., Synthesis, characterization and cytotoxicity of photo-crosslinked maleic chitosan-polyethylene glycol diacrylate hybrid hydrogels. Acta Biomaterialia, 2010. 6(10): p. 3908-3918. 114. Kehrer, J.P., The Haber-Weiss reaction and mechanisms of toxicity. Toxicology, 2000. 149(1): p. 43-50. 115. Lynn, A.D., T.R. Kyriakides, and S.J. Bryant, Characterization of the in vitro macrophage response and in vivo host response to poly(ethylene glycol)-based hydrogels. Journal of Biomedical Materials Research Part A, 2010. 93A(3): p. 941-953. 116. Mc Bath, R.A. and D.A. Shipp, Swelling and degradation of hydrogels synthesized with degradable poly(beta-amino ester) crosslinkers. Polymer Chemistry, 2010. 1(6): p. 860-865. 117. Cruise, G.M., D.S. Scharp, and J.A. Hubbell, Characterization of permeability and network structure of interfacially photopolymerized poly(ethylene glycol) diacrylate hydrogels. Biomaterials, 1998. 19(14): p. 1287-1294. 118. Whang, K., et al., Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture. Tissue Eng, 1999. 5(1): p. 35-51. 119. Watson, P.G. and R.D. Young, Scleral structure, organisation and disease. A review. Exp Eye Res, 2004. 78(3): p. 609-623. 120. Petsche, S.J., et al., Depth-dependent transverse shear properties of the human corneal stroma. Invest Ophthalmol Vis Sci, 2012. 53(2): p. 873-880. 121. Hatami-Marbini, H., Viscoelastic shear properties of the corneal stroma. J Biomech, 2014. 47(3): p. 723-728. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/78169 | - |
dc.description.abstract | 角膜為一無血管、折射光線之透明組織,並有提供眼睛外層屏障等多種功能。目前由文獻統計顯示因疾病或創傷所造成之角膜致盲已影響了數千萬人口的生活,大多數人皆以角膜移植的手術方式作為視力回復的手段,然而過去有過失敗的移植經驗、角膜血管化等高風險患者若進行角膜移植手術,因排斥導致失敗的機率相當高而不適用,另一方面,由於現今雷射手術的發達以及疾病感染的增加,致使健康的捐贈角膜也日漸缺乏,因此人工角膜的發展成為未來的必然走向,也逐漸成為患者的新希望。
人工角膜一般可以分成兩個部分:中央光學區與幫助眼表代謝、固定光學區之角膜襯裙。於本研究中,吾人使用聚乙二醇雙丙烯酸酯(polyethylene glycol diacrylate, PEGDA)、泊洛沙姆407雙丙烯酸酯(Poloxamer 407, P407DA)以及單-(甲基丙烯酰氧丙基)聚二甲基矽氧烷(Mono-methacryloxypropyl terminated polydimethylsiloxane, mPDMS)之巨分子單體,以不同比例的配方混合後光交聯製備具多孔性的水膠材料。 研究結果可以發現以PEGDA為主要成分加入其他兩者材料時,初步以澎潤測試,當加入mPDMS時會使原先較親水的結構變得稍微疏水一些而使澎潤比下降,但隨著P407DA的使用量增加,會使澎潤性質逐漸回復近只有PEGDA單體製成水膠的程度。由掃描式電子顯微鏡 (SEM)直接觀察水膠樣品皆具開放性的多孔結構,並於加入mPDMS後孔洞尺寸顯著變小,而P407DA加入時則使孔洞變大,此結果在孔隙分析的部分相互呼應。在動態機械性質方面,以流變儀測量剪力儲存模數,只以PEGDA與mPDMS作成的水膠機械性質強度明顯增加,而P407DA加入,孔洞的尺寸逐漸上升,其機械性質的強度隨之變低。在加速氧化測試的結果中,只要mPDMS的水膠其被氧化使結構破碎的時間皆較長,但當P407DA加入至一定程度時,可能因孔洞變大而使結構較脆弱而使水膠破碎的時間變短。另一方面,於大鼠的皮下植入結果顯示,當水膠的孔徑越大時周圍之細胞聚集越多,而材料降解的情形仍然發生。總體來說,以含矽材料加入水膠之中能夠增進機械性質並延長降解時間,雖然以生物實驗結果上不甚理想,但高孔隙率以及大孔洞的特性,仍舊使本研究中的水膠樣品具有作為人工角膜襯裙之潛力存在。 | zh_TW |
dc.description.abstract | The human cornea is a non-vascularized and optically transparent tissue with appropriate curvature surface that refracts light rays and serves as the outermost protective barrier of eye. Corneal opaci-fication from disease or trauma is estimated to affect more than 10 million people worldwide, and corneal transplant has become the most common surgical treatment to recover patients’ vision. However, corneal transplant is not applicable for patients with high-risks (e.g., ones who suffered from previous graft rejection, vascularization of recipient cornea, etc.), and thus, artificial cornea becomes a viable option. Artificial cornea is divided into two parts: the optical center and a ring of keratoprosthesis skirt. The keratoprosthesis skirt fixes the artificial cornea to the host sclera and serves to transfer nutrients and maintains ocular surface metabolism.
In this study, three hydrogel components were tested as potential materials to be used for the construction of keratoprosthesis skirt: 1) polyethylene glycol diacrylate (PEGDA) and 2) poloxamer 407 diacrylate (P407DA) make up the high porosity framework, while 3) silicone-containing mono-methacryloxypropyl terminated polydimethylsiloxane’s (mPDMS) properties improves oxygen permeability and mechanical strength. Based on the swelling test, hydrogels containing mPDMS material were more hydrophobic than the ones containing PEGDA. Direct observation under the scanning electron microscope (SEM) and mercury porosimeter revealed that all hydrogels possess porous structure with open pores. The application of different amounts of P407DA can regulate pore size and porosity. According to the dynamic mechanical analysis, only hydrogels containing PEGDA and mPDMS have larger shear storage modulus, and that increasing the amount of P407DA de-creases the shear storage modulus. The accelerated oxidation test showed that hydrogels containing mPDMS have greater stability (longer degradation time) than the ones containing PEGDA. In conclusion, silicone-based material can promote mechanical strength and prolong degrada-tion time. We believe the high porosity and large open pores in these hydrogels have the potential to serve as the raw material for keratoprosthesis skirt of artificial cornea. | en |
dc.description.provenance | Made available in DSpace on 2021-07-11T14:44:32Z (GMT). No. of bitstreams: 1 ntu-105-R03524010-1.pdf: 4772638 bytes, checksum: 3341bf4daee583c4387dc5f434a7d3e7 (MD5) Previous issue date: 2016 | en |
dc.description.tableofcontents | 誌謝 I
中文摘要 III ABSTRACTV 目錄 VII 圖目錄 IX 表目錄 XI 1 第一章 緒論 p.1 1.1 研究動機 p.1 1.2 章節概述 p.2 2 第二章 文獻回顧 p.3 2.1 角膜結構 p.3 2.2 角膜致盲之治療方法 p.5 2.2.1 捐贈角膜移植(Keratoplasty) p.5 2.2.2 人工角膜移植(Keratoprosthesis) p.7 2.3 人工角膜介紹 p.8 2.3.1 波士頓人工角膜(Boston keratoprosthesis) p.8 2.3.2 AlphaCor p.15 2.3.3 骨齒人工角膜(Osteo-odonto-keratoprosthesis,OOKP) p.18 2.3.4 Seoul-type人工角膜(Seoul-type keratoprosthesis, Seoul Kpro) p.19 2.3.5 KeraKlear 人工角膜(KeraKlear Kpro) p.22 2.3.6 Fyodorov-Zuev人工角膜(Fyodorov-Zuev keratoprosthesis) p.24 2.3.7 材料的改良 p.25 2.4 水凝膠(HYDROGEL) p.29 2.4.1 聚乙二醇水膠(Polyethylene glycol hydrogel, PEG hydrogel) p.31 2.4.2 泊洛沙姆407(Poloxamer 407, P407) p.32 2.4.3 聚二甲基矽氧烷(Polydimethylsiloxane, PDMS) p.34 2.5 水膠合成原理 p.35 2.5.1 親核性醯基取代反應(Nucleophilic acyl substitution p.36 2.5.2 溶劑誘導相分離(Solvent induced phase separation) p.38 2.6 性質測試儀器 p.42 2.6.1 掃描式電子顯微鏡(Scanning Electron Microscope) p.42 2.6.2 核磁共振光譜(Nuclear magnetic resonance spectroscopy) p.44 2.6.3 流變儀(Rheometer) p.46 3 第三章 實驗方法 p.48 3.1 實驗藥品與儀器 p.48 3.2 親核醯基取代反應合成末端雙烯化之巨分子單體 p.51 3.2.1 合成乙二醇雙丙烯酸酯( (Poly(ethylene glycol diacrylate, PEGDA) p.51 3.2.2 合成泊洛沙姆407雙丙烯酸酯(Pluronic F-127 diacrylate (P407DA)) p.52 3.3 水膠合成 p.53 3.4 巨分子單體與水膠特性檢測 p.55 3.4.1 氫核磁共振光譜(1H Nuclear magnetic resonance) p.55 3.4.2 水膠澎潤測試(Equilibrium swelling test) p.55 3.4.3 掃描式電子顯微鏡(Scanning electron microscopy) p.56 3.4.5 加速氧化降解測試(Accelerated oxidative degradation test) p.57 3.4.6 水銀測孔儀(Mercury Porosimetry) p.59 3.4.7 皮下植入實驗(Subcutaneous implantation studies) p.60 4 第四章 結果與討論 p.61 4.1 PEG與P407經氫核磁共振光譜測定之烯化率 p.61 4.2 水膠澎潤平衡 p.63 4.3 水膠孔洞型態 p.64 4.3.1 SEM觀察結果 p.64 4.3.2 水銀測孔儀結果 p.68 4.4 動態機械性質 p.70 4.5 加速氧化測試 p.72 4.6 皮下植入實驗 p.73 5 第五章 結論與未來展望 p.74 參考文獻 p.76 | |
dc.language.iso | zh-TW | |
dc.title | 矽水膠人工角膜襯裙之開發與測試 | zh_TW |
dc.title | Development and Characterization of Keratoprosthesis
Skirt Using Silicone-Hydrogel Material | en |
dc.type | Thesis | |
dc.date.schoolyear | 104-2 | |
dc.description.degree | 碩士 | |
dc.contributor.coadvisor | 戴子安(Chi-An Dai) | |
dc.contributor.oralexamcommittee | 廖思婷,吳宛儒,林達顯,賴進此 | |
dc.subject.keyword | 水膠,矽成分,角膜襯裙,生醫材料, | zh_TW |
dc.subject.keyword | Hydrogel,Silicone-containing,cornea skirt,biomaterial, | en |
dc.relation.page | 85 | |
dc.identifier.doi | 10.6342/NTU201601804 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2016-08-02 | |
dc.contributor.author-college | 工學院 | zh_TW |
dc.contributor.author-dept | 化學工程學研究所 | zh_TW |
顯示於系所單位: | 化學工程學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-105-R03524010-1.pdf 目前未授權公開取用 | 4.66 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。